LamdaGen Corporation Receives Notice of Allowance to Grant European Patent for Enzymatic Assays Performed on LSPR Based Plasmonic Nano-Sensors
Patent for Ultra-Sensitive and Rapid Assay System MENLO PARK, CA, June 22, 2015 — LamdaGen Corporation, a leading developer of diagnostic biosensors, today announced it has received notification from the European Patent Office (EPO) of its intention to grant the Continue reading